Skip to main content
Top

memo - Magazine of European Medical Oncology

Issue 2/2015

Content (13 Articles)

editorial

PET/CT in management of oncologic patients

Siroos Mirzaei, Abass Alavi

review

New targets in breast cancer

Ami Jhaveri, Lajos Pusztai

review

New targets in gastric cancer

Nikita M. Volkov

short review

New targets in metastatic colorectal cancer

Herbert Ulrich-Pur

review

Role of FDG-PET/CT in staging and first-line treatment of Hodgkin and aggressive B-cell lymphomas

Theodoros P. Vassilakopoulos, Vassilios Prassopoulos, Phoivi Rondogianni, Sofia Chatziioannou, Kostas Konstantopoulos, Maria K. Angelopoulou

short review

Amino acid PET monitoring in gliomas

Ulrich Roelcke

review

The relevance of positron emission tomography response in non-small cell lung cancer

Amanda Tufman, Ullrich Müller-Lisse, Simone Reu, Rudolf Maria Huber, Frank Berger

short review

The role of positron emission tomography in breast cancer: a short review

Maria Adele Marino, Thomas H. Helbich, Alfredo Blandino, Katja Pinker

original report

Lung cancer in Bulgaria ‒ diagnosis, treatment, and factors affecting survival

Zhasmina Mihaylova, Vera Megdanova, Veneta Petrova, Dobromira Petkova, Albena Fakirova, Mihaela Petrova, Rumen Asenov, Iva Kisjova, Milena Encheva, Hristo Dinev

Case report

Cytomegalovirus retinitis in a child with lymphoblastic lymphoma

Shahla Ansari, Azadeh Kiumarsi, Tahereh Rostami

case report

Esthesioneuroblastoma metastatic to the neck and lung: a case report and review of the literature

Sepúlveda Ilson, Max Schorwer, Michael Frelinghuysen, Enrique Platin, Carolina Delgado, Francisco Mucientes

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine